Based on retrospective observational studies, low-dose acetylsalicylic acid reduced incidence of venous thrombosis in JAK2V617F-mutated patients, while in CALR-mutated patients it did not affect the risk of thrombosis but was associated with a higher incidence of bleeding [30]. This evidence concerns the gene CALR and Venous thrombosis.